Reaction
Stoma Creation reporting signals
As of the last recalculation, Stoma Creation appears in 664 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is RISANKIZUMAB-RZAA (PRR 94.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Risankizumab-Rzaa | 180 | 94.3 | 94.5 |
| Upadacitinib | 125 | 59.0 | 59.1 |
| Infliximab-Dyyb | 30 | 33.6 | 33.7 |
| Vedolizumab | 34 | 13.0 | 13.0 |
| Ustekinumab | 33 | 10.6 | 10.6 |
| Trifluridine And Tipiracil | 3 | 8.8 | 8.8 |